$400.54▲ 4.26 (1.07%)
Real-time prices · US MarketsConsistently beats earnings estimates (4/4 quarters).
earnings contracting 13% year-over-year.
Quality
4.9
Health
7.6
Growth
4.4
Valuation
6.7
Sentiment
7.2
Analyst Target
$449.10
▲ +12.1% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
17.7×
price-to-earnings
Forward P/E
13.5×
next 12 months est.
Market Cap
$86.9B
market capitalization
Div Yield
1.72%
dividend yield
Profit Margin
2.5%
net profit margin
Gross Margin
26.0%
revenue minus COGS
ROE
11.1%
return on equity
Beta
0.69
vs S&P 500
52-Week Range
$275 — $436
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
What do analysts say about Elevance Health, Inc. right now?
Elevance Health, Inc.'s Q·Score is 6/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. Consistently beats earnings estimates (4/4 quarters). Key area to monitor: earnings contracting 13% year-over-year. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for ELV?
The consensus price target for ELV is $449.10, based on ratings from 21 Wall Street analysts. This is 12.1% above the current price of $400.54. Price targets are forward-looking estimates and not guarantees of future performance.
Is ELV overvalued or undervalued?
Elevance Health, Inc. (ELV) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 13.5×. The consensus analyst price target of $449.10 is 12% above the current price.
When does Elevance Health, Inc. report its next earnings?
Elevance Health, Inc.'s next earnings report is expected on approximately October 21, 2026.
What is Elevance Health, Inc.'s profit margin?
Elevance Health, Inc. has a net profit margin of 2.5%, which is positive but relatively thin. Its gross margin stands at 26.0%, reflecting a more cost-intensive business model.
What is ELV's dividend yield?
Elevance Health, Inc. currently offers a dividend yield of 1.72%, a modest payout typical for growth-oriented companies. Dividend yields can change based on price movements and company payout decisions.
Is Elevance Health, Inc.'s revenue growing?
Elevance Health, Inc. is reporting modest revenue growth of 1.4%. However, earnings declined 13.1%, which warrants monitoring.
How much debt does Elevance Health, Inc. have?
Elevance Health, Inc. has a debt-to-equity ratio of 0.69×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 1.52×, indicating comfortable short-term liquidity.
Compare ELV with any stock